Clinical trial
Genetic Risk for Attention Deficit Hyperactivity Disorder Expressed in Brain…
NCT00143832 · UMC Utrecht, Other · Unknown status
Key facts
| NCT number | NCT00143832 |
|---|---|
| Title | Genetic Risk for Attention Deficit Hyperactivity Disorder Expressed in Brain Functioning |
| Official title | Genetic Risk for Attention Deficit Hyperactivity Disorder Expressed in Brain Functioning |
| Lead sponsor | UMC Utrecht, Other |
| Collaborators | Netherlands Organisation for Scientific Research |
| Status | Unknown status |
| Study type | Observational |
| Conditions | Attention Deficit Hyperactivity Disorder |
| Enrollment | 90 |
| Start date | Sep 1, 2004 |
| First posted | Sep 2, 2005 |
| Last update posted | Mar 20, 2007 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: